Teknova Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
211
- Stock Symbol
-
TKNO
- Share Price
-
$4.92
- (As of Friday Closing)
Teknova General Information
Description
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.
Contact Information
Website
www.teknova.comCorporate Office
- 2290 Bert Drive
- Hollister, CA 95023
- United States
Corporate Office
- 2290 Bert Drive
- Hollister, CA 95023
- United States
Teknova Timeline
Teknova Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.92 | $5.06 | $1.16 - $5.46 | $262M | 53.3M | 621K | -$0.93 |
Teknova Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 65,692 | 150,647 | 144,762 | 487,497 |
| Revenue | 34,940 | 36,684 | 41,420 | 36,893 |
| EBITDA | (27,077) | (30,585) | (46,439) | (9,165) |
| Net Income | (34,270) | (36,780) | (47,468) | (9,803) |
| Total Assets | 115,353 | 128,587 | 152,261 | 166,511 |
| Total Debt | 30,975 | 30,458 | 42,310 | 11,870 |
Teknova Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Teknova Comparisons
Industry
Financing
Details
Teknova Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| InVitria | Corporation | Junction City, KS |
Teknova Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Teknova Patents
Teknova Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-2020383-A | Coupling for connection to a gas bottle | Active | 05-May-1978 | ||
| GB-2020383-B | Coupling for connection to a gas bottle | Inactive | 05-May-1978 | ||
| ES-221552-U | New coupling device in the discharge nozzle of a gas bottle. (machine-translation by google translate, not legally binding) | Active | 09-Jun-1975 | ||
| GB-1512317-A | Flow connector for connection to a tubular spigot for example the discharge spout of a gas bottle | Inactive | 09-Jun-1975 | ||
| FR-2314431-A1 | Housing seal for mechanical coupling to a nozzle, for example the nozzle of a gas bottle | Inactive | 09-Jun-1975 | F16L37/121 |
Teknova Executive Team (7)
| Name | Title | Board Seat |
|---|---|---|
| Stephen Gunstream | Chief Executive Officer & Board Member | |
| Matthew Lowell | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting | |
| Damon Terrill | General Counsel, Legal & Chief Compliance Officer, Legal |
Teknova Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brett Robertson JD | Self | Board Member | |
| Irene Davis | Self | Board Member | |
| Stephen Gunstream | Teknova | Chief Executive Officer & Board Member |
Teknova Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Teknova Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Teknova ESG
Risk Overview
Risk Rating
Updated July, 27, 2023
29.32 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,842
Rank
Percentile
Pharmaceuticals
Industry
of 898
Rank
Percentile
Pharmaceuticals
Subindustry
of 428
Rank
Percentile
Teknova FAQs
-
When was Teknova founded?
Teknova was founded in 1996.
-
Who is the CEO of Teknova?
Stephen Gunstream is the CEO of Teknova.
-
Where is Teknova headquartered?
Teknova is headquartered in Hollister, CA.
-
What is the size of Teknova?
Teknova has 211 total employees.
-
What industry is Teknova in?
Teknova’s primary industry is Specialty Chemicals.
-
Is Teknova a private or public company?
Teknova is a Public company.
-
What is Teknova’s stock symbol?
The ticker symbol for Teknova is TKNO.
-
What is the current stock price of Teknova?
As of 04-Oct-2024 the stock price of Teknova is $4.92.
-
What is the current market cap of Teknova?
The current market capitalization of Teknova is $262M.
-
What is Teknova’s current revenue?
The trailing twelve month revenue for Teknova is $34.9M.
-
Who are Teknova’s competitors?
InVitria is a competitor of Teknova.
-
What is Teknova’s annual earnings per share (EPS)?
Teknova’s EPS for 12 months was -$0.93.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
